- Home
- BRKR
BRKR
Bruker Corporation
as 10-21-2024 4:00pm EST
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
| Founded: | 1991 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 9.5B | IPO Year: | 2000 |
| Target Price: | $79.60 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.39 | EPS Growth: | 10.49 |
| 52 Week Low/High: | $53.79 - $94.86 | Next Earning Date: | 10-31-2024 |
| Revenue: | $3,119,700,000 | Revenue Growth: | 14.93% |
| Revenue Growth (this year): | 17.05% | Revenue Growth (next year): | 9.28% |
Stock Insider Trading Activity of Bruker Corporation (BRKR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ROSENTHAL BOB | BRKR | Director | Aug 15 '24 | Sell | $63.14 | 4,684 | $295,747.76 | 30,963 |
Latest Bruker Corporation News
BRKR Breaking Stock News: Dive into BRKR Ticker-Specific Updates for Smart Investing
Business Wire
20 hours ago
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
Zacks
5 days ago
BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division
MT Newswires
5 days ago
Bruker's NanoString Unit Wins European Patent Lawsuit Against 10x Genomics
Business Wire
5 days ago
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
GlobeNewswire
5 days ago
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
Insider Monkey
5 days ago
Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now?
Business Wire
11 days ago
Bruker Announces Formation of New Bruker Spatial Biology Division
Simply Wall St.
12 days ago
US Growth Stocks With High Insider Ownership In October 2024
Compare BRKR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRKR Bruker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.